ACTRIMS 2024: Repeated Autologous Mesenchymal Stem Cell Transplants Aid Cognition in Patients With Progressive MS
Significant beneficial effects also seen for objective biomarkers of neurodegeneration and neuroinflammation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.